WEREWOLF THERAPEUTICS INC's ticker is HOWL and the CUSIP is 95075A107. A total of 51 filers reported holding WEREWOLF THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,000 | – | 335 | +16650.0% | 0.00% | – |
Q1 2023 | $0 | – | 2 | 0.0% | 0.00% | – |
Q4 2022 | $0 | -100.0% | 2 | -99.5% | 0.00% | – |
Q3 2022 | $2,000 | +100.0% | 387 | +66.1% | 0.00% | – |
Q2 2022 | $1,000 | -85.7% | 233 | -85.6% | 0.00% | – |
Q1 2022 | $7,000 | -89.7% | 1,622 | -71.4% | 0.00% | – |
Q4 2021 | $68,000 | +385.7% | 5,680 | +613.6% | 0.00% | – |
Q3 2021 | $14,000 | +55.6% | 796 | +53.4% | 0.00% | – |
Q2 2021 | $9,000 | – | 519 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DC Funds, LP | 589,102 | $1,796,761 | 38.27% |
MPM ASSET MANAGEMENT LLC | 4,284,172 | $13,066,725 | 6.41% |
MPM BioImpact LLC | 2,388,011 | $7,283,434 | 1.47% |
RA Capital Management | 6,144,881 | $18,741,887 | 0.35% |
SPHERA FUNDS MANAGEMENT LTD. | 626,810 | $1,911,771 | 0.30% |
PFM Health Sciences, LP | 2,303,891 | $7,026,868 | 0.27% |
Rubric Capital Management LP | 1,935,357 | $5,902,839 | 0.25% |
Alyeska Investment Group, L.P. | 397,808 | $1,213,314 | 0.01% |
Laurion Capital Management LP | 522,900 | $1,594,845 | 0.01% |
Schonfeld Strategic Advisors LLC | 326,702 | $996,441 | 0.01% |